Promising new drugs for old pathogen Mtb
Tuberculosis (TB), an ancient and notoriously difficult disease to treat, has killed millions through the course of human history; and ...
Tag: Infectious/Emerging Diseases
WHO guidelines fail to detect half of chronic hepatitis B patients in Ethiopia needing treatment
Scientists propose revising the guidelines to take data from sub-Saharan Africa into account, reports the Journal of Hepatology Amsterdam, March ...
The Lancet Infectious Diseases: Low levels of public trust during violent conflict may have thwarted attempts to control Ebola
A quarter of people surveyed during active 2018 Ebola outbreak in the Democratic Republic of Congo believed the virus was ...
Dramatic housing transformation in sub-Saharan Africa revealed for first time
Improved housing estimated to have doubled between 2000 and 2015 but nearly 50 percent of the urban population still living ...
Sepsis study to focus on genes in quest for treatments
Scientists say the study could help identify those most vulnerable to sepsis, which kills more than 50,000 people in the ...
Retinal prion disease study redefines role for brain cells
Microglia may benefit, not damage, photoreceptorsCredit: James. F. Striebel/NIAID WHAT: National Institutes of Health scientists studying the progression of inherited ...
Study: AIDS-immunocompromised populations see more antibiotic-resistant infections
Populations with a high prevalence of AIDS-immunocompromised people are more likely to see the emergence of antibiotic-resistant bacterial infections, according ...
Microgels let medical implants fight off bacteria
Implants coated in microgel flecks could be key to reducing surgical infections Joint replacements are among the most common elective ...
Researchers unlock the biomechanics of how the Ebola virus attaches to its host cell
Lehigh University engineers, working with microbiologists at the University of Iowa, have developed a simple model for virus-host cell interaction ...
New VaxArray neuraminidase potency test for N9
InDevR launches first-in-class reagent kit for rapid quantification of N9 in 'pandemic' influenza vaccinesCredit: InDevR BOULDER COLORADO (3/26/19) -- InDevR ...
New angle of attack drives cellular HIV-reservoirs to self-destruction
While current therapies for HIV can successfully manage active infection, the virus can survive in tissue reservoirs, including macrophage cells, ...
Can you 'catch' cancer?
Parasitic worms cause cancer -- and could help cure it Billions worldwide are infected with tropical worms. Unsurprisingly, most of ...
Giving intravenous therapy to children at home is costly, lowers parents’ quality of life
(Salt Lake City) - When treating patients, doctors sometimes overlook how their decisions impact a world they never see: a ...
Aspirin to fight an expensive global killer infection
Centenary Institute in Sydney has found a brand new target for treating drug-resistant tuberculosis; our scientists have uncovered that the ...
POPULAR NEWS
-
Insilico Medicine receives IND approval from FDA for novel MAT2A inhibitor ISM3412
-
San Antonio-based SwRI to construct first facility outside of Texas
-
Targeted use of enfortumab vedotin for the treatment of advanced urothelial carcinoma
-
Professor Miguel Ángel García receives the prestigious ERC Advanced Grant from the European Research Council